Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone prophylaxis duration in subtalar fusion
NCT06527989Phase 3Not yet recruiting
- Sponsor
- Assiut University
- Start
- Sep 2024
- Primary completion
- Sep 2025
- Modality
- Reversible Covalent Inhibitors
01
Overview
A Phase 3 trial of ceftriaxone in surgical site infection (SSI), sponsored by Assiut University. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
ceftriaxone
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT06527989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06527989.